(Q46384949)

English

High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

10

object named as

R Storb

1 reference

Europe PubMed Central

21 December 2017

author name string

F Baron

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

M B Maris

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

B E Storer

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

B M Sandmaier

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

J P Panse

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

T R Chauncey

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

M Sorror

7

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

M-T Little

8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

D G Maloney

9

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

S Heimfeld

11

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

publication date

1 May 2005

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

19

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

822-828

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403718

0 references

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Bone marrow transplantation: how important is CD34 cell dose in HLA-identical stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

21 January 2018

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

7 January 2021

based on heuristic

inferred from DOI database lookup

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

7 January 2021

based on heuristic

inferred from DOI database lookup

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403718

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403718

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15772701

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46384949&oldid=2109123423"